Zefia Watson

Doctor of Medicine,  Toronto General - University Health Network 

Location: India

Consulting Services

Grant Submission Hospital-Pharmacy-Insurance

Areas Of Interest

Diagnostic Technic, Radioisotope Low-Protein Diet gamma-L-Glutamyl-L-Cysteinylglycine V(D)J Recombinase Antigen Presentations Analogs, Prostaglandin F Perlinganit Calcium Sulfate, Anhydrous Elevator Hyperglycemic Hyperosmolar Nonketotic Coma Syndromes, Postcholedochostomy G-Protein, G13 Subunit Endobulin Syndromes, Neurofibromatosis Lipidome Disease, Rosai-Dorfman Catapres Peptic Ulcer Hemorrhages NSC 609699 NSC299195 Thymine Cyclobutane Dimer Permeability Factor, Duran-Reynals erbB Oncogene Proteins Care Act, Affordable (ACA) SF-86-327 delta-Chain, T-Cell Receptor Medial Dorsal Thalamic Nucleus Human Viral Hepatitides Skin Disease, Bacterial Pilins Crabgrass Achalasias DNA Oxidative Demethylase ALKBH1 Plasmacytoma Growth Factor Recruitment Activity

Professional Narrative

Dr. Zefia Watson was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Watson has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Executive Director, Harvard Med 2004
Assistant Professor, Amgen 2001

Education

Doctor of medicine, Baylor College 1994
Director Medicine, Baylor College 2016

Referees


Publications

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Mitchell MJ, Billingsley MM, Haley RM, Wechsler ME, Peppas NA, Langer R. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4. PMID: 33277608; PMCID: PMC7717100.

Gupta A, Andresen JL, Manan RS, Langer R. Nucleic acid delivery for therapeutic applications. Adv Drug Deliv Rev. 2021 Nov;178:113834. doi: 10.1016/j.addr.2021.113834. Epub 2021 Sep 4. PMID: 34492233.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :